|
This report is being submitted to relay additional information.The following sections are being reported: b4: date of this report was updated.G3: date received by manufacturer was updated.G6: type of report was updated.H2: type of follow up was updated.H3: device evaluated by manufacturer was updated.H6: component code was added: 4755.H6: tyoe of investigation codes were added: 10, 4109, 3331, 4110 and 4111.H6: investigation findings code was added: 213.H6: investigation conclusions code was added: 67 and 4310.H10: narrative/data was updated.The product was returned and the reported event was unconfirmed following functional testing.Based on the evaluation, device malfunction has not occurred.Additionally, there is no existing nonconformance / capa / hhe/d / ie / product hold against the reported device that did or could cause or contribute to the reported event.Monthly post market trending review identified no actionable trends or corrective actions for the reported event or device.Zimmer biomet quality management system (qms) has controls in place to ensure the distribution of conforming products.Therefore, based on the available information, the product was within specifications and conforming when it left zimmer biomet.Dhr review for the lots (1243390) had revealed no deviations nor non-conformances which could have caused or contributed to the reported event.Complaint history review was performed for the reported lot number (1243390) for similar events (complaint category keywords: does not seat) and no other complaints were identified.Functional testing was performed with an in-house implant.The device was able to seat onto the implant as normal.Therefore, the reported event couldn't be recreated.The complaint is related to the functional performance of the device.A definitive root cause could not be determined.However, those probable causes are not applicable to this investigation since device malfunction did not occur and the reported event was unconfirmed following functional testing.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the product was nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.
|